Overview
ISO/TR 21582:2021 - "Pyrogenicity - Principles and methods for pyrogen testing of medical devices" is a technical report from ISO/TC 194 that summarizes principles, methods and practical considerations for assessing pyrogenicity of medical devices and their materials. The document addresses causes of febrile responses (pyrogens), test selection and procedures, and the current state of accepted methods for devices that contact blood, lymph, cerebrospinal fluid (CSF) or otherwise interact systemically with humans.
Key Topics
- Scope and definitions: clear definitions of pyrogen, pyrogenicity, febrile response, and medical device as applied to testing.
- Characterization of pyrogens:
- Bacterial endotoxin (lipopolysaccharide, LPS) as a potent TLR4-mediated pyrogen and its structural determinants (lipid A, acylation/phosphorylation).
- Microbial components other than endotoxin (e.g., lipoteichoic acid, lipopeptides, viral dsRNA, flagellin, CpG DNA) and their TLR/NOD pathways.
- Material-mediated pyrogenicity from chemical agents and other non-microbial sources.
- Principles of febrile reaction: role of Toll-like receptors (TLRs), cytokine signaling and systemic responses.
- Assessment methods:
- Bacterial Endotoxin Test (BET) using Limulus amebocyte lysate (LAL): principle, general procedure and properties.
- Rabbit pyrogen test: in vivo procedure, principle, characteristics.
- Human cell‑based pyrogen test (HCPT) (e.g., monocyte activation test): human-cell selection, marker cytokines, procedures and validation considerations.
- Practical considerations: sample preparation, limitations of sterilization (endotoxin is not inactivated by standard sterilization), and depyrogenization options such as high‑temperature treatment (e.g., 250 °C for 30 min), polymyxin-B or use of endotoxin‑free water.
Applications
Who uses ISO/TR 21582:2021 and why:
- Medical device manufacturers - design testing strategies for devices with systemic exposure (blood, CSF), establish supplier controls and manufacturing depyrogenization.
- Quality assurance and regulatory affairs - align pyrogen testing approaches with international best practice when preparing regulatory submissions or risk assessments.
- Testing laboratories and contract research organizations - select and validate appropriate pyrogen tests (BET, rabbit test, HCPT) and interpret results relative to device use.
- Clinical safety evaluators and toxicologists - understand mechanisms (TLRs, cytokines) and limitations of each test for safety assessment.
Keywords: ISO/TR 21582:2021, pyrogenicity, pyrogen testing, medical devices, bacterial endotoxin test, BET, LAL, rabbit pyrogen test, human cell-based pyrogen test, HCPT.
Related Standards
- ISO 10993 series (notably ISO 10993-11:2017 Annex G reference to material-mediated pyrogenicity)
- Relevant pharmacopoeias and regulatory guidelines for BET and pyrogen testing (as referenced in the report).
